TY - JOUR
T1 - Invited commentary
T2 - recommendation for a north american pediatric patch test series.
AU - Jacob, Sharon E.
AU - Admani, Shehla
AU - Herro, Elise M.
N1 - Funding Information:
Conflict of Interest Sharon E. Jacob and Elise M. Herro served as investigators on the safety and efficacy of T.R.U.E. Test™ (Smart Practice; Phoenix, AZ) panels 1.1, 2.1, and 3.1 in children and adolescents, Pediatric Research Equity Act (PREA-1) trial. Dr. Jacob has also served as a consultant for Johnson & Johnson. Sharon E. Jacob and Shehla Admani are currently investigators on the PREA-2 trial, and Shehla Admani is a research fellow at UCSD/Rady Children’s Hospital funded by a grant from the National Psoriasis Foundation.
PY - 2014/6
Y1 - 2014/6
N2 - Given the increased recognition of pediatric allergic contact dermatitis and lack of patch testing consensus in children, we present a minimum basic 20-allergen North American pediatric series, for screening children ages 6-12 with suspected contact allergy.
AB - Given the increased recognition of pediatric allergic contact dermatitis and lack of patch testing consensus in children, we present a minimum basic 20-allergen North American pediatric series, for screening children ages 6-12 with suspected contact allergy.
UR - https://www.scopus.com/pages/publications/84900873689
UR - https://www.scopus.com/pages/publications/84900873689#tab=citedBy
U2 - 10.1007/s11882-014-0444-6
DO - 10.1007/s11882-014-0444-6
M3 - Article
C2 - 24744270
SN - 1529-7322
VL - 14
JO - Current allergy and asthma reports
JF - Current allergy and asthma reports
IS - 6
M1 - 444
ER -